Research suggests that larch arabinogalactan may support immune function through several proposed pathways, including activation of natural killer cells and macrophages, promotion of beneficial gut bacteria, and modulation of gut-associated immune tissue, though the precise mechanisms remain incompletely understood. The available evidence includes two review articles and one randomized controlled trial, with findings generally leaning supportive but mixed overall — the RCT found a meaningful reduction in cold frequency among healthy adults, while reviews noted encouraging laboratory and animal data alongside limited human evidence, particularly in contexts relying on T cell activity. Studies indicate that some uncertainty remains around whether observed effects are driven by direct immune stimulation, changes in the gut microbiome, or a combination of both, and the RCT's finding that those who did get sick reported more severe initial symptoms adds a layer of complexity that researchers have not yet fully explained. As with many dietary supplements, the current body of evidence is preliminary, and larger and more varied clinical trials would be needed before firm conclusions can be drawn.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Does larch arabinogalactan enhance immune function? A review of mechanistic a... | Review | 2016 | Mixed | 100 |
| Larch arabinogalactan: clinical relevance of a novel immune-enhancing polysac... | Review | 1999 | Supports | 95 |
| Larch arabinogalactan effects on reducing incidence of upper respiratory infe... | RCT | 2013 | Mixed | 90 |